What is the maximum dose of Lasix (furosemide) for intravenous administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Intravenous Push Dose for Furosemide

The maximum rate for intravenous push administration of furosemide is 4 mg/min, and individual bolus doses should not exceed 80-100 mg given over 1-2 minutes for standard IV push administration. 1

FDA-Approved Administration Guidelines

The FDA label provides explicit instructions for IV push furosemide administration 1:

  • Standard IV bolus: 20-40 mg given slowly over 1-2 minutes as initial dose
  • Repeat dosing: May increase by 20 mg increments, given not sooner than 2 hours after previous dose
  • Acute pulmonary edema: Initial 40 mg IV push over 1-2 minutes; if inadequate response after 1 hour, may increase to 80 mg IV push over 1-2 minutes
  • Maximum infusion rate: When using high-dose parenteral therapy via continuous infusion, rate must not exceed 4 mg/min 1

High-Dose Administration Protocols

For doses exceeding standard bolus amounts, specific precautions apply 1:

  • High-dose therapy: Must be given as controlled IV infusion, not rapid push
  • Preparation requirements: Add furosemide to normal saline, lactated Ringer's, or D5W after adjusting pH above 5.5
  • Rate limitation: Controlled infusion at ≤4 mg/min to prevent ototoxicity 1
  • Avoid acidic solutions: Do not mix with acidic medications (labetalol, ciprofloxacin, amrinone, milrinone) as precipitation occurs 1

Maximum Dosing by Clinical Context

Acute Heart Failure

  • First 6 hours: Total dose should not exceed 100 mg 2
  • First 24 hours: Total dose should not exceed 240 mg 2
  • Continuous infusion: 5-10 mg/hour, with maximum rate of 4 mg/min during administration 2

Cirrhosis with Ascites

  • Maximum daily dose: 160 mg/day (typically combined with spironolactone) 3, 2
  • Exceeding this threshold: Indicates diuretic resistance requiring alternative strategies 3, 2

Pediatric Patients

  • Standard dose: 1 mg/kg IV push given slowly 1
  • Maximum single dose: 6 mg/kg body weight 1
  • Premature infants: Should not exceed 1 mg/kg/day 1

Critical Safety Considerations

Ototoxicity Prevention

The rate of administration is crucial to prevent hearing loss 2, 4:

  • Infusions must be given over 5-30 minutes when doses exceed standard bolus amounts
  • Rapid IV push of large doses significantly increases ototoxicity risk
  • Maximum rate of 4 mg/min must be strictly observed 1

Absolute Contraindications to Administration

Do not administer furosemide IV push if 2, 4:

  • Anuria is present
  • Systolic blood pressure <90 mmHg without circulatory support
  • Severe hyponatremia (serum sodium <120-125 mmol/L)
  • Marked hypovolemia or hypotension
  • Within 12 hours of last fluid bolus or vasopressor administration

Common Pitfalls to Avoid

Never push large doses rapidly 1: The 1-2 minute administration time applies only to standard 20-80 mg boluses. Higher doses require controlled infusion at ≤4 mg/min to prevent ototoxicity and acute hemodynamic changes.

Do not exceed 100 mg in first 6 hours in acute heart failure 2: Aggressive early dosing beyond this threshold increases nephrotoxicity risk without improving outcomes.

Avoid mixing with acidic solutions 1: Furosemide has pH ~9 and precipitates below pH 7. Never add to running IV lines containing acidic medications.

Monitor for acute renal deterioration 4: Creatinine increases >0.3 mg/dL during treatment are associated with 3-fold higher mortality risk. Doses >60-80 mg daily significantly increase renal function deterioration.

References

Guideline

Furosemide Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Furosemide and Albumin Use in Critical Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.